| Michael B Mosleth, MD | |
|
1527 Broadway St, Alexandria, MN 56308-2537 | |
| (320) 762-0399 | |
| Not Available |
| Full Name | Michael B Mosleth |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 1527 Broadway St, Alexandria, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457381576 | NPI | - | NPPES |
| P00663088 | Other | WI | RR MEDICARE |
| 30342200 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 23323 (Wisconsin) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 24099 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael B Mosleth, MD 1527 Broadway St, Alexandria, MN 56308-2537 Ph: (320) 762-0399 | Michael B Mosleth, MD 1527 Broadway St, Alexandria, MN 56308-2537 Ph: (320) 762-0399 |
News Archive
Today Future Science Group announces the publication of an article in Future Virology highlighting the clinical complications associated with antiretroviral therapy in Chinese HIV/ Tuberculosis (TB) coinfected patients.
A new statistical analysis supports beliefs that COVID-19 became more lethal in the U.K. in late 2020, while also suggesting that multiple factors-;not just the alpha variant of the virus that causes COVID-19-;were to blame.
Meridian announced today strong results for the second quarter of 2009, with this being the second consecutive quarter of exceptional revenue and earnings. These results will undoubtedly help Meridian and its parent company, Visionary Integration Professionals (VIP), end 2009 with an exceptional three-year compound annual growth rate (CAGR). Between 2008 and 2005, Meridian and VIP posted a CAGR of 72.8 percent.
Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc., today announced that it has completed enrollment of its ADVANCE-PD trial. ADVANCE-PD is a multinational Phase III trial of its late-stage product IPX066 in advanced Parkinson's disease (PD) patients with motor fluctuations. IPX066 is an investigational extended release carbidopa-levodopa product intended to rapidly achieve and sustain effective blood concentrations of levodopa, potentially improving PD clinical symptom management.
Opioid use among women trying to conceive may be associated with a lower chance of pregnancy, suggests a National Institutes of Health study. Moreover, opioid use in early pregnancy may be associated with a greater chance of pregnancy loss.
› Verified 7 days ago
Jessica M Butanis, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 610 30th Ave W, Alexandria, MN 56308 Phone: 320-763-5123 Fax: 320-763-7883 | |
Andrea M Boe, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 515 22nd Ave E, Alexandria, MN 56308 Phone: 320-759-2640 Fax: 320-759-2023 | |
Dr. Jayme Michael Danielson, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 610 30th Ave W, Alexandria, MN 56308 Phone: 320-763-2540 Fax: 320-763-5749 | |
Isam M Alakhras, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 610 30th Avenue West, Alexandria Clinic Pa, Alexandria, MN 56308 Phone: 320-763-5123 Fax: 320-763-7883 | |
Dr. Skyler Holte Dahlseng, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 610 30th Ave W, Alexandria, MN 56308 Phone: 320-763-2540 Fax: 320-763-7883 | |
Jeffrey R Olive, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 610 30th Ave West, Alexandria Clinic, Alexandria, MN 56308 Phone: 320-763-5123 Fax: 320-763-7883 |